Gapping up
In reaction to strong earnings/guidance:
- PVH +6.7% , KMX +4.6%, WBA +4.6%, CXW +1.9% (withdraws FY20 financial guidance; confirms Q1 guidance), ASND +1.8%, NG +1.6%
Other news:
- MUR +10.7% (cuts dividend in half; also reduces 2020 capital plan)
- AFMD +6.9% (provides COVID-19 update)
- MAXR +6.5% (received favorable arbitral tribunal decision)
- ARNC +6.3% (to join S&P SmallCap 600)
- EIGR +6.3% (provides update on clinical development operations during COVID-19 pandemic)
- FTI +6.3% (announces actions to address current market conditions)
- AAL +5.8% (discloses borrowings under revolving facilities)
- RCL +5.8% (provided notice to the lenders under each of the Revolving Credit Facilities to complete its draw down of all remaining commitments under each Revolving Credit Facility on March 27)
- RRTS +5.2% (sells its dry van business unit)
- VNE +4% (to split JV with Volvo)
- ETH +3.5% (provides action plan in response to the COVID-19 health crisis; halts buy back)
- BUD +3.1% (gets regulatory approval to sell its Australian subsidiary)
- CME +2.3% (reports all-time high ADV for March and Q1)
Analyst comments:
- TDC +4.8% (upgraded to Buy from Sell at Citigroup)
- MMP +3.9% (upgraded to Outperform from Neutral at Credit Suisse)
- CXP +3.1% (upgraded to Buy from Neutral at Goldman)
- WU +3% (upgraded to Buy from Underperform at BofA/Merrill)
- HSIC +2.9% (upgraded to Outperform from Peer Perform at Wolfe Research)
- ICPT +2.7% (initiated with Buy at Chardan)
- DIS +2.2% (upgraded to Overweight from Neutral at Atlantic Equities)
- BMY +2.1% (upgraded to Overweight from Equal-Weight at Morgan Stanley)